nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—TUBB—Docetaxel—melanoma	0.516	0.717	CbGbCtD
Podofilox—CYP3A4—Temozolomide—melanoma	0.117	0.163	CbGbCtD
Podofilox—CYP3A4—Vemurafenib—melanoma	0.0641	0.0892	CbGbCtD
Podofilox—CYP3A4—Docetaxel—melanoma	0.022	0.0306	CbGbCtD
Podofilox—Skin papilloma—Vemurafenib—melanoma	0.0102	0.125	CcSEcCtD
Podofilox—Localized exfoliation—Bleomycin—melanoma	0.0075	0.0916	CcSEcCtD
Podofilox—TOP2A—Paclitaxel—Docetaxel—melanoma	0.00483	1	CbGdCrCtD
Podofilox—Tenderness—Bleomycin—melanoma	0.00231	0.0283	CcSEcCtD
Podofilox—Dry skin—Vemurafenib—melanoma	0.00222	0.0271	CcSEcCtD
Podofilox—Ulcer—Bleomycin—melanoma	0.00214	0.0261	CcSEcCtD
Podofilox—Ulcer—Dactinomycin—melanoma	0.00199	0.0243	CcSEcCtD
Podofilox—Skin exfoliation—Bleomycin—melanoma	0.00193	0.0236	CcSEcCtD
Podofilox—Skin exfoliation—Carmustine—melanoma	0.00168	0.0206	CcSEcCtD
Podofilox—Redness—Docetaxel—melanoma	0.00168	0.0205	CcSEcCtD
Podofilox—Skin exfoliation—Temozolomide—melanoma	0.00163	0.0199	CcSEcCtD
Podofilox—Erythema—Vemurafenib—melanoma	0.00146	0.0178	CcSEcCtD
Podofilox—Swelling—Carmustine—melanoma	0.00145	0.0177	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00123	0.0151	CcSEcCtD
Podofilox—Inflammation—Docetaxel—melanoma	0.00117	0.0143	CcSEcCtD
Podofilox—Skin disorder—Vemurafenib—melanoma	0.00116	0.0141	CcSEcCtD
Podofilox—Dry skin—Temozolomide—melanoma	0.00113	0.0139	CcSEcCtD
Podofilox—Skin exfoliation—Docetaxel—melanoma	0.00108	0.0132	CcSEcCtD
Podofilox—Haematuria—Bleomycin—melanoma	0.00108	0.0132	CcSEcCtD
Podofilox—Haemoglobin—Bleomycin—melanoma	0.00102	0.0125	CcSEcCtD
Podofilox—Haemorrhage—Bleomycin—melanoma	0.00101	0.0124	CcSEcCtD
Podofilox—Swelling—Docetaxel—melanoma	0.000932	0.0114	CcSEcCtD
Podofilox—Etoposide—PTGS2—melanoma	0.000911	0.541	CrCbGaD
Podofilox—Haemoglobin—Carmustine—melanoma	0.00089	0.0109	CcSEcCtD
Podofilox—Haemorrhage—Carmustine—melanoma	0.000885	0.0108	CcSEcCtD
Podofilox—Erythema—Bleomycin—melanoma	0.000883	0.0108	CcSEcCtD
Podofilox—Dermatitis bullous—Docetaxel—melanoma	0.000861	0.0105	CcSEcCtD
Podofilox—Haemoglobin—Temozolomide—melanoma	0.00086	0.0105	CcSEcCtD
Podofilox—Haemorrhage—Temozolomide—melanoma	0.000856	0.0105	CcSEcCtD
Podofilox—Pruritus—Vemurafenib—melanoma	0.000841	0.0103	CcSEcCtD
Podofilox—TUBB—hair follicle—melanoma	0.000829	0.154	CbGeAlD
Podofilox—Erythema—Dactinomycin—melanoma	0.000823	0.0101	CcSEcCtD
Podofilox—Dizziness—Vemurafenib—melanoma	0.000786	0.00961	CcSEcCtD
Podofilox—Etoposide—ABCB1—melanoma	0.000775	0.46	CrCbGaD
Podofilox—Immune system disorder—Temozolomide—melanoma	0.000773	0.00944	CcSEcCtD
Podofilox—Erythema—Carmustine—melanoma	0.000771	0.00942	CcSEcCtD
Podofilox—Vomiting—Vemurafenib—melanoma	0.000756	0.00924	CcSEcCtD
Podofilox—Dry skin—Docetaxel—melanoma	0.000754	0.00921	CcSEcCtD
Podofilox—Rash—Vemurafenib—melanoma	0.00075	0.00916	CcSEcCtD
Podofilox—Dermatitis—Vemurafenib—melanoma	0.000749	0.00916	CcSEcCtD
Podofilox—Headache—Vemurafenib—melanoma	0.000745	0.00911	CcSEcCtD
Podofilox—Erythema—Temozolomide—melanoma	0.000745	0.0091	CcSEcCtD
Podofilox—Oedema—Bleomycin—melanoma	0.000721	0.00881	CcSEcCtD
Podofilox—Oedema—Dactinomycin—melanoma	0.000672	0.00821	CcSEcCtD
Podofilox—Paraesthesia—Bleomycin—melanoma	0.000647	0.00791	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00063	0.0077	CcSEcCtD
Podofilox—Oedema—Carmustine—melanoma	0.000629	0.00769	CcSEcCtD
Podofilox—Pain—Bleomycin—melanoma	0.000616	0.00753	CcSEcCtD
Podofilox—Oedema—Temozolomide—melanoma	0.000608	0.00743	CcSEcCtD
Podofilox—Skin disorder—Temozolomide—melanoma	0.00059	0.00722	CcSEcCtD
Podofilox—Pain—Dactinomycin—melanoma	0.000575	0.00702	CcSEcCtD
Podofilox—Haemoglobin—Docetaxel—melanoma	0.000572	0.00699	CcSEcCtD
Podofilox—Haemorrhage—Docetaxel—melanoma	0.000569	0.00695	CcSEcCtD
Podofilox—Insomnia—Carmustine—melanoma	0.000569	0.00695	CcSEcCtD
Podofilox—Paraesthesia—Carmustine—melanoma	0.000565	0.0069	CcSEcCtD
Podofilox—TUBA4A—eye—melanoma	0.000564	0.105	CbGeAlD
Podofilox—TUBA4A—retina—melanoma	0.000559	0.104	CbGeAlD
Podofilox—Insomnia—Temozolomide—melanoma	0.00055	0.00672	CcSEcCtD
Podofilox—Paraesthesia—Temozolomide—melanoma	0.000546	0.00667	CcSEcCtD
Podofilox—Pain—Carmustine—melanoma	0.000538	0.00657	CcSEcCtD
Podofilox—Pain—Temozolomide—melanoma	0.00052	0.00635	CcSEcCtD
Podofilox—Immune system disorder—Docetaxel—melanoma	0.000514	0.00628	CcSEcCtD
Podofilox—Pruritus—Bleomycin—melanoma	0.00051	0.00623	CcSEcCtD
Podofilox—Erythema—Docetaxel—melanoma	0.000495	0.00605	CcSEcCtD
Podofilox—TUBA4A—skin of body—melanoma	0.000491	0.0913	CbGeAlD
Podofilox—Vomiting—Bleomycin—melanoma	0.000458	0.0056	CcSEcCtD
Podofilox—Rash—Bleomycin—melanoma	0.000454	0.00555	CcSEcCtD
Podofilox—Dermatitis—Bleomycin—melanoma	0.000454	0.00555	CcSEcCtD
Podofilox—TUBA4A—mammalian vulva—melanoma	0.000448	0.0833	CbGeAlD
Podofilox—Pruritus—Temozolomide—melanoma	0.00043	0.00526	CcSEcCtD
Podofilox—Vomiting—Dactinomycin—melanoma	0.000427	0.00522	CcSEcCtD
Podofilox—Rash—Dactinomycin—melanoma	0.000424	0.00518	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000419	0.00512	CcSEcCtD
Podofilox—Dizziness—Carmustine—melanoma	0.000416	0.00508	CcSEcCtD
Podofilox—Oedema—Docetaxel—melanoma	0.000404	0.00494	CcSEcCtD
Podofilox—Dizziness—Temozolomide—melanoma	0.000402	0.00491	CcSEcCtD
Podofilox—Vomiting—Carmustine—melanoma	0.0004	0.00489	CcSEcCtD
Podofilox—Rash—Carmustine—melanoma	0.000397	0.00485	CcSEcCtD
Podofilox—Dermatitis—Carmustine—melanoma	0.000396	0.00484	CcSEcCtD
Podofilox—Headache—Carmustine—melanoma	0.000394	0.00482	CcSEcCtD
Podofilox—Skin disorder—Docetaxel—melanoma	0.000393	0.0048	CcSEcCtD
Podofilox—Vomiting—Temozolomide—melanoma	0.000386	0.00472	CcSEcCtD
Podofilox—Rash—Temozolomide—melanoma	0.000383	0.00468	CcSEcCtD
Podofilox—Dermatitis—Temozolomide—melanoma	0.000383	0.00468	CcSEcCtD
Podofilox—Headache—Temozolomide—melanoma	0.000381	0.00465	CcSEcCtD
Podofilox—Insomnia—Docetaxel—melanoma	0.000366	0.00447	CcSEcCtD
Podofilox—Paraesthesia—Docetaxel—melanoma	0.000363	0.00444	CcSEcCtD
Podofilox—Pain—Docetaxel—melanoma	0.000346	0.00422	CcSEcCtD
Podofilox—TOP2A—mammalian vulva—melanoma	0.000331	0.0616	CbGeAlD
Podofilox—TUBB—mammalian vulva—melanoma	0.000328	0.061	CbGeAlD
Podofilox—TUBA4A—head—melanoma	0.00032	0.0596	CbGeAlD
Podofilox—Pruritus—Docetaxel—melanoma	0.000286	0.00349	CcSEcCtD
Podofilox—Dizziness—Docetaxel—melanoma	0.000267	0.00327	CcSEcCtD
Podofilox—NR3C1—neck—melanoma	0.000258	0.0479	CbGeAlD
Podofilox—Vomiting—Docetaxel—melanoma	0.000257	0.00314	CcSEcCtD
Podofilox—Rash—Docetaxel—melanoma	0.000255	0.00311	CcSEcCtD
Podofilox—Dermatitis—Docetaxel—melanoma	0.000255	0.00311	CcSEcCtD
Podofilox—Headache—Docetaxel—melanoma	0.000253	0.00309	CcSEcCtD
Podofilox—TUBA4A—lymph node—melanoma	0.000224	0.0417	CbGeAlD
Podofilox—NR3C1—eye—melanoma	0.000192	0.0356	CbGeAlD
Podofilox—NR3C1—skin of body—melanoma	0.000167	0.031	CbGeAlD
Podofilox—TOP2A—lymph node—melanoma	0.000166	0.0309	CbGeAlD
Podofilox—TUBB—lymph node—melanoma	0.000164	0.0306	CbGeAlD
Podofilox—NR3C1—mammalian vulva—melanoma	0.000152	0.0283	CbGeAlD
Podofilox—CYP2C19—Biological oxidations—CYP17A1—melanoma	0.000122	0.000651	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—MYC—melanoma	0.00012	0.000644	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CYP17A1—melanoma	0.00012	0.000643	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.000119	0.000638	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—APEX1—melanoma	0.000118	0.000631	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—IGF1—melanoma	0.000117	0.000627	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.000117	0.000625	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.000116	0.000621	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—PIK3CA—melanoma	0.000116	0.00062	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDK2—melanoma	0.000115	0.000617	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—MMP1—melanoma	0.000115	0.000616	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN2B—melanoma	0.000114	0.00061	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.000114	0.000609	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—melanoma	0.000113	0.000605	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.000113	0.000603	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PIK3CD—melanoma	0.000112	0.000602	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—RB1—melanoma	0.000112	0.000597	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—melanoma	0.000111	0.000594	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—ALB—melanoma	0.000111	0.000594	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.00011	0.000589	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.00011	0.000588	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CDKN2A—melanoma	0.00011	0.000586	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—ATM—melanoma	0.00011	0.000586	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.000109	0.000585	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDK4—melanoma	0.000109	0.000583	CbGpPWpGaD
Podofilox—NR3C1—head—melanoma	0.000109	0.0202	CbGeAlD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—melanoma	0.000108	0.000576	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—RB1—melanoma	0.000106	0.000567	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—PTEN—melanoma	0.000105	0.000564	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—E2F1—melanoma	0.000105	0.00056	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TP53—melanoma	0.000103	0.000549	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—PRKCA—melanoma	0.000103	0.000548	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—CYP1B1—melanoma	0.000103	0.000548	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN2B—melanoma	0.000102	0.000545	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CYP1B1—melanoma	0.000101	0.000541	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	9.92e-05	0.000531	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—PCNA—melanoma	9.87e-05	0.000528	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CDKN2A—melanoma	9.8e-05	0.000524	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PIK3CB—melanoma	9.8e-05	0.000524	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CDKN1B—melanoma	9.71e-05	0.000519	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MDM2—melanoma	9.51e-05	0.000509	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—RB1—melanoma	9.48e-05	0.000507	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—AKT1—melanoma	9.47e-05	0.000507	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—CTNNB1—melanoma	9.4e-05	0.000503	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—IL6—melanoma	9.39e-05	0.000502	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	9.38e-05	0.000502	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—E2F1—melanoma	9.36e-05	0.000501	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDKN2A—melanoma	9.32e-05	0.000499	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	9.3e-05	0.000497	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CCND1—melanoma	9.26e-05	0.000496	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—IGF1—melanoma	9.21e-05	0.000493	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—CDKN1A—melanoma	9.18e-05	0.000491	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—PRKCA—melanoma	9.17e-05	0.00049	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—melanoma	9.13e-05	0.000488	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—TP53—melanoma	9.04e-05	0.000483	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDK2—melanoma	9.03e-05	0.000483	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—IL2—melanoma	9e-05	0.000482	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CDKN1A—melanoma	8.96e-05	0.000479	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	8.93e-05	0.000478	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	8.93e-05	0.000478	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—MMP2—melanoma	8.92e-05	0.000477	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—PCNA—melanoma	8.82e-05	0.000472	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CXCL8—melanoma	8.8e-05	0.000471	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CDKN1B—melanoma	8.68e-05	0.000464	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDK4—melanoma	8.53e-05	0.000456	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TERT—melanoma	8.52e-05	0.000456	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—melanoma	8.5e-05	0.000455	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	8.43e-05	0.000451	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CASP3—melanoma	8.42e-05	0.000451	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN2A—melanoma	8.34e-05	0.000446	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CCND1—melanoma	8.28e-05	0.000443	CbGpPWpGaD
Podofilox—CYP3A4—Tryptophan metabolism—MDM2—melanoma	8.28e-05	0.000443	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IL6—melanoma	8.27e-05	0.000442	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDKN1B—melanoma	8.26e-05	0.000442	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—STAT3—melanoma	8.19e-05	0.000438	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CTNNB1—melanoma	8.12e-05	0.000434	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MDM2—melanoma	8.09e-05	0.000432	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDK2—melanoma	8.07e-05	0.000432	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CDKN1A—melanoma	8.01e-05	0.000429	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—NFKB1—melanoma	7.88e-05	0.000421	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CCND1—melanoma	7.88e-05	0.000421	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CUBN—melanoma	7.76e-05	0.000415	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	7.75e-05	0.000414	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—melanoma	7.71e-05	0.000412	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—RPS3—melanoma	7.67e-05	0.00041	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—ATM—melanoma	7.66e-05	0.00041	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—VEGFA—melanoma	7.65e-05	0.000409	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MAPK3—melanoma	7.64e-05	0.000409	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—AKT1—melanoma	7.63e-05	0.000408	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDK4—melanoma	7.63e-05	0.000408	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDKN1A—melanoma	7.62e-05	0.000408	CbGpPWpGaD
Podofilox—NR3C1—lymph node—melanoma	7.62e-05	0.0142	CbGeAlD
Podofilox—TUBA4A—Hemostasis—NRAS—melanoma	7.56e-05	0.000404	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—SKI—melanoma	7.55e-05	0.000404	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—SNRPE—melanoma	7.55e-05	0.000404	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—melanoma	7.5e-05	0.000401	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MYC—melanoma	7.43e-05	0.000397	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—RB1—melanoma	7.42e-05	0.000397	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—CXCL8—melanoma	7.41e-05	0.000396	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN1B—melanoma	7.38e-05	0.000395	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP17A1—melanoma	7.32e-05	0.000392	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MAPK1—melanoma	7.27e-05	0.000389	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—GPAM—melanoma	7.26e-05	0.000388	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—MAPK3—melanoma	7.24e-05	0.000387	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	7.22e-05	0.000386	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—TP53—melanoma	7.2e-05	0.000385	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—CDKN2B—melanoma	7.17e-05	0.000384	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—VEGFA—melanoma	7.15e-05	0.000382	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—TNF—melanoma	7.09e-05	0.000379	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CCND1—melanoma	7.04e-05	0.000377	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—VDR—melanoma	6.99e-05	0.000374	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—MAPK1—melanoma	6.89e-05	0.000368	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—CTNNB1—melanoma	6.84e-05	0.000366	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ACER3—melanoma	6.83e-05	0.000366	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MAPK3—melanoma	6.83e-05	0.000365	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN1A—melanoma	6.81e-05	0.000364	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MYC—melanoma	6.64e-05	0.000355	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—RB1—melanoma	6.63e-05	0.000355	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—IL6—melanoma	6.59e-05	0.000352	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN2A—melanoma	6.52e-05	0.000349	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—KRAS—melanoma	6.5e-05	0.000348	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MAPK1—melanoma	6.5e-05	0.000348	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MAPK3—melanoma	6.5e-05	0.000347	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	6.33e-05	0.000339	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MYC—melanoma	6.32e-05	0.000338	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—UGT2B10—melanoma	6.25e-05	0.000334	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MAPK1—melanoma	6.18e-05	0.000331	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	6.17e-05	0.00033	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP1B1—melanoma	6.16e-05	0.00033	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—TNF—melanoma	6.13e-05	0.000328	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	6.08e-05	0.000325	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PIK3CA—melanoma	5.98e-05	0.00032	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NPPA—melanoma	5.91e-05	0.000316	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN2A—melanoma	5.83e-05	0.000312	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HS3ST5—melanoma	5.81e-05	0.000311	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MAPK3—melanoma	5.81e-05	0.000311	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TP53—melanoma	5.78e-05	0.000309	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN1B—melanoma	5.77e-05	0.000309	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—IL6—melanoma	5.72e-05	0.000306	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MDM2—melanoma	5.65e-05	0.000302	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MYC—melanoma	5.65e-05	0.000302	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—HRAS—melanoma	5.53e-05	0.000296	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MAPK1—melanoma	5.53e-05	0.000296	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CCND1—melanoma	5.51e-05	0.000295	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TP53—melanoma	5.46e-05	0.000292	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN1A—melanoma	5.33e-05	0.000285	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—NOTCH1—melanoma	5.16e-05	0.000276	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN1B—melanoma	5.16e-05	0.000276	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL6—melanoma	4.94e-05	0.000264	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CCND1—melanoma	4.93e-05	0.000263	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—AKT1—melanoma	4.88e-05	0.000261	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—PPARG—melanoma	4.87e-05	0.000261	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN1A—melanoma	4.76e-05	0.000255	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	4.68e-05	0.00025	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TP53—melanoma	4.64e-05	0.000248	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MAPK3—melanoma	4.54e-05	0.000243	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MYC—melanoma	4.42e-05	0.000236	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PLCB4—melanoma	4.4e-05	0.000236	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MAPK1—melanoma	4.32e-05	0.000231	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—FASN—melanoma	4.32e-05	0.000231	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—HDAC2—melanoma	4.32e-05	0.000231	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC6A11—melanoma	4.14e-05	0.000221	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIP4K2A—melanoma	4.14e-05	0.000221	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ACER3—melanoma	4.11e-05	0.00022	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MAPK3—melanoma	4.06e-05	0.000217	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MTAP—melanoma	4.03e-05	0.000215	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MYC—melanoma	3.95e-05	0.000211	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.94e-05	0.000211	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MAPK1—melanoma	3.87e-05	0.000207	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—UGT2B10—melanoma	3.76e-05	0.000201	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PHGDH—melanoma	3.59e-05	0.000192	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—LUM—melanoma	3.59e-05	0.000192	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HPSE—melanoma	3.52e-05	0.000188	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HS3ST5—melanoma	3.49e-05	0.000187	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CUBN—melanoma	3.46e-05	0.000185	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—CDKN2B—melanoma	3.45e-05	0.000185	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—VDR—melanoma	3.37e-05	0.00018	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SDHD—melanoma	3.34e-05	0.000179	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—BSG—melanoma	3.34e-05	0.000179	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CSPG4—melanoma	3.34e-05	0.000179	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TP53—melanoma	3.24e-05	0.000174	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GPAM—melanoma	3.23e-05	0.000173	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PRKCA—melanoma	3.1e-05	0.000166	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—ERCC2—melanoma	3.08e-05	0.000165	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—MYC—melanoma	2.78e-05	0.000149	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PLA2G6—melanoma	2.75e-05	0.000147	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PLCB4—melanoma	2.65e-05	0.000142	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIP4K2A—melanoma	2.49e-05	0.000133	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC6A11—melanoma	2.49e-05	0.000133	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NOTCH1—melanoma	2.49e-05	0.000133	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—VCAN—melanoma	2.47e-05	0.000132	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MTAP—melanoma	2.42e-05	0.00013	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PPARG—melanoma	2.35e-05	0.000126	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.34e-05	0.000125	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.26e-05	0.000121	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—LUM—melanoma	2.16e-05	0.000115	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PHGDH—melanoma	2.16e-05	0.000115	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HPSE—melanoma	2.12e-05	0.000113	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP17A1—melanoma	2.08e-05	0.000111	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CUBN—melanoma	2.08e-05	0.000111	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.05e-05	0.00011	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	2.03e-05	0.000108	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SDHD—melanoma	2.01e-05	0.000107	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—BSG—melanoma	2.01e-05	0.000107	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CSPG4—melanoma	2.01e-05	0.000107	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GNA11—melanoma	1.97e-05	0.000105	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GPAM—melanoma	1.94e-05	0.000104	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—FASN—melanoma	1.92e-05	0.000103	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC5A5—melanoma	1.89e-05	0.000101	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CD44—melanoma	1.83e-05	9.78e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GNAQ—melanoma	1.83e-05	9.78e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.79e-05	9.58e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.77e-05	9.49e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP1B1—melanoma	1.75e-05	9.38e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PLA2G6—melanoma	1.65e-05	8.84e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.55e-05	8.28e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—VCAN—melanoma	1.48e-05	7.94e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCB1—melanoma	1.44e-05	7.72e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MAPK3—melanoma	1.38e-05	7.36e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MYC—melanoma	1.34e-05	7.16e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PRKCA—melanoma	1.33e-05	7.11e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ERCC2—melanoma	1.32e-05	7.05e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP17A1—melanoma	1.25e-05	6.7e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GNA11—melanoma	1.18e-05	6.33e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—FASN—melanoma	1.16e-05	6.19e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC5A5—melanoma	1.14e-05	6.09e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GNAQ—melanoma	1.1e-05	5.88e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CD44—melanoma	1.1e-05	5.88e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.09e-05	5.84e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP1B1—melanoma	1.05e-05	5.64e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CG—melanoma	1.04e-05	5.57e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PPARG—melanoma	1e-05	5.37e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—AKT1—melanoma	9.28e-06	4.96e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CD—melanoma	9.15e-06	4.89e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALB—melanoma	9.03e-06	4.83e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCB1—melanoma	8.68e-06	4.64e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PRKCA—melanoma	7.99e-06	4.27e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CB—melanoma	7.97e-06	4.27e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ERCC2—melanoma	7.92e-06	4.24e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTGS2—melanoma	7.9e-06	4.23e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTEN—melanoma	6.89e-06	3.69e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CG—melanoma	6.26e-06	3.35e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PPARG—melanoma	6.04e-06	3.23e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CD—melanoma	5.5e-06	2.94e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALB—melanoma	5.43e-06	2.91e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CA—melanoma	4.86e-06	2.6e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CB—melanoma	4.8e-06	2.57e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTGS2—melanoma	4.75e-06	2.54e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTEN—melanoma	4.14e-06	2.22e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—AKT1—melanoma	3.97e-06	2.12e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CA—melanoma	2.92e-06	1.56e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—AKT1—melanoma	2.39e-06	1.28e-05	CbGpPWpGaD
